Skip to Content

Atropine Pregnancy and Breastfeeding Warnings

Atropine is also known as: Atreza, AtroPen, Sal-Tropine

Atropine Pregnancy Warnings

Safety has not been established during pregnancy; use is recommended only if clearly needed and the benefit outweighs the risk. AU TGA pregnancy category: A US FDA pregnancy category: C

Animal studies are insufficient regarding reproductive toxicity; one study showed no evidence of fetal harm, another high dose study showed a teratogenic effect in one animal species. This drug crosses the placenta and may cause tachycardia in the fetus. There are no controlled data in human pregnancy, however it has been used by a large number of pregnant women without an increase in the frequency of malformations or other direct or indirect harmful effects on the fetus being observed. AU TGA pregnancy category A: Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed. US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Atropine Breastfeeding Warnings

This drug should be used only if absolutely necessary. Excreted into human milk: Yes Comments: -Small amounts appear in breast milk and may have antimuscarinic effects in the infant. -Lactation may be inhibited. -Infants are usually very sensitive to the effects of this drug.

See references

References for pregnancy information

  1. "Product Information. Atropine Sulfate (atropine)." American Regent Laboratories Inc, Shirley, NY.
  2. "Product Information. Atropine Sulfate Injection, USP (atropine)." ESI Lederle Generics, Philadelphia, PA.
  3. Cerner Multum, Inc. "Australian Product Information." O 0
  4. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  5. "Product Information. AtroPen (atropine)." Meridian Medical Technologies Inc, Columbia, MD.

References for breastfeeding information

  1. "Product Information. AtroPen (atropine)." Meridian Medical Technologies Inc, Columbia, MD.
  2. "Product Information. Atropine Sulfate (atropine)." American Regent Laboratories Inc, Shirley, NY.
  3. "Product Information. Atropine Sulfate Injection, USP (atropine)." ESI Lederle Generics, Philadelphia, PA.
  4. Cerner Multum, Inc. "Australian Product Information." O 0

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide